国际麻醉学与复苏杂志   2012, Issue (8): 0-0
    
不同剂量右美托咪定在腹腔镜妇科手术中的应用
雷晓鸣, 钞海莲, 倪秀梅, 薛荣亮1()
1.西安交通大学医学院第二附属医院
Clinical observation of different doses of dexmedetomidine applied in laparoscopic gynecological surgery
 全文:
摘要:

目的 探讨不同剂量右美托咪啶(dexmedetomidine, DEX)用于腹腔镜妇科手术的有效性和安全性。 方法 美国麻醉医师协会(ASA)分级 I一Ⅱ级全麻下择期行腹腔镜妇科手术80例,按随机数字表法分为4组,每组20例:A组(10 ml生理盐水),B组(0.25 µg/kg DEX)、C组(0.5 µg/kgDEX)、D组(1.0 µg/kgDEX), 麻醉诱导前4组分别用微量泵恒速输注10 min生理盐水、不同剂量DEX(用生理盐水稀释至10 ml),记录入室15 min后(T0)、输注DEX后(T1)、气管插管前(T2)、插管后(T3)、气腹后(T4)、切皮后(T5)、术毕(T6)和拔管(T7)各时间点动脉压[收缩压(SBP)、舒张压(DBP)]、心率(HR)、脑电双频谱指数(BIS)值,记录苏醒时间、拔管时间、丙泊酚和瑞芬太尼的用药总量以及围手术期副作用。 结果 A组、B组各时间点的SBP、DBP、HR较诱导前显著升高,而C、D组无明显变化,插管后血压、HR低于同时点的A组和B组,与诱导前比较差异无统计学意义, D组T1与T0时比较,HR显著降低(P<0.05),SBP、DBP升高(P<0.05); 4组丙泊酚用量分别为 (834±109、725±94、615±110、563±97)mg, 瑞芬太尼用量分别为(562±53、497±32、431±41、442±37)µg;4组患者的苏醒时间、拔管时间组间比较差异无统计学意义(P>0.05);围术期麻黄素和阿托品的使用次数,D组比A、B、C组增多(P<0.05);苏醒期寒战、躁动及呛咳发生率,C组、D组比A组、B组减少(P<0.05)。结论  0.25、0.5和1.0 µ g/kg 3种剂量的DEX可以对腹腔镜妇科手术的患者产生良好的镇静作用,减少丙泊酚和瑞芬太尼用量,减少麻醉苏醒期副作用的发生。DEX0.5 µg/kg 麻醉诱导前单次静脉输注更为平稳。

关键词: 右美托咪定;腹腔镜妇科手术;血流动力学;镇静;不良反应
Abstract:

Objective To investigate the efficacy and safety of different doses of dexmedetomidine(DEX) administered in the laparoscopic gynecological surgery. Methods Eighty patients ASA grades Ⅰ or Ⅱ, scheduled for elective laparoscopic gynecological surgery under general anesthesia were randomly divided into four groups, 20 patients in each group: group A (Control group, 10ml normal saline), group B (0.25μg/kg DEX), group C (0.5μg/kg DEX ), group D (1.0μg/kg DEX). Before induction of anesthesia, patients were administered intravenously 10ml saline or different doses of dexmedetomidine (diluted with saline to 10ml) in 10minutes with syringe pump respectively. Systolic blood pressure(SBP), diastolic blood pressure(DBP), heart rate(HR) and bispectral index(BIS) value were recorded 15min after entering operating room(T0), after given dexmedetomidine infusion(T1),immediately before and after tracheal intubation(T2-T3), after pneumoperitoneu (T4), after skin incision (T5), at the end of surgery (T6) and extubation(T7), meanwhile the amount of propofol and remifentanil, recovery time, extubation time and adverse reactions were also recorded. Results In group A, B, SBP, DBP and HR at each time after intubation was significantly higher than that before induction, while in group C, D there were no significant changes in those parameters among the different time points. SBP, DBP and HR after intubation in group C and group D were lower than that at the same time point in group A and group B. At time point T1, HR were significantly decreased and SBP, DBP increased compared with that at time point T0. Values of BIS were significantly lower at time point T1 in group B, C and D (P<0.05) compared with that at time point T0. Values of BIS at time point T1 in group B, C were significantly higher (P<0.05) compared with that in group D. There were significant differences in the doses of propofol administered in four groups (P<0.05), the doses were(834±109, 725±94, 615±110, 563±97)mg in group A, group B, group C and group D respectively. The doses of remifentanil used in four groups were respectively (562±53, 497±32, 431±41, 442±37)µg. Recovery time and extubation time of the patients among 4 group were no statistically significant different (P >0.05). The dosage of epherine and atropine administered in group D increased obviously (P<0.05) and higher incidence of chill, dysphoria and cough was observed in group A and group B(P<0.05). Conclusions:Before induction of anesthesia, administration of different doses of DEX have significant sedative effects on patients, can reduce the dose of propofol and remifentanil and may reduce the adverse reactions. Cardiovascular parameter changes was more stable within different stage of surgery in the group which 0.5μg/kg DEX was administered before anesthesia.

Key words: Dexmedetomidine;Laparoscopic gynecological surgery; Hemodynamics;Sedation;Adverse reactions